Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: J Thorac Oncol. 2013 Nov;8(11):1378–1388. doi: 10.1097/JTO.0b013e3182a46c0c

Figure 5.

Figure 5

Other genetic alterations in p16-RB pathway in NSCLC cell lines. The percentages of cell lines containing RB mutations, CCND1, CDK4 and CDK6 copy number gains are plotted. Copy numbers >3 are considered as copy number gains.